COLORECTAL CANCER METASTATIC
Clinical trials for COLORECTAL CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new COLORECTAL CANCER METASTATIC trials appear
Sign up with your email to follow new studies for COLORECTAL CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to keep peritoneal cancer at bay after surgery
Disease control Not yet recruitingThis study tests whether adding lubiprostone to standard maintenance therapy can delay cancer recurrence in people with colorectal cancer that has spread to the lining of the abdomen (peritoneum). About 124 adults who have had surgery to remove visible tumors will be randomly ass…
Matched conditions: COLORECTAL CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Could a poop pill boost cancer treatment? new trial tests gut bacteria transplant for tough colorectal tumors
Disease control Not yet recruitingThis early study tests whether transplanting gut bacteria from young donors (fecal transplant) can make standard immunotherapy and chemotherapy work better for people with advanced colorectal cancer that hasn't responded to prior treatment. Ten patients will receive the combinati…
Matched conditions: COLORECTAL CANCER METASTATIC
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
Triple attack: virus therapy plus two drugs targets liver metastases in colorectal cancer
Disease control Not yet recruitingThis early-stage study tests a new treatment for people with colorectal cancer that has spread to the liver and hasn't responded to standard therapies. The treatment combines a modified virus (BioTTT001) that targets cancer cells, with two drugs (toripalimab and regorafenib) that…
Matched conditions: COLORECTAL CANCER METASTATIC
Phase: PHASE1 • Sponsor: China Medical University, China • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for Hard-to-Treat colorectal cancer: Triple-Drug combo targets liver tumors
Disease control Not yet recruitingThis study tests a combination of three drugs (balstilimab, botensilimab, and agenT-797) in adults with a type of colorectal cancer that has spread to the liver and hasn't responded to prior treatments. The goal is to see if the combination can shrink tumors and what side effects…
Matched conditions: COLORECTAL CANCER METASTATIC
Phase: PHASE2 • Sponsor: Darren Sigal, MD • Aim: Disease control
Last updated May 14, 2026 12:02 UTC